Godavari Biorefineries receives US patent for cancer fighting novel class of compounds

Godavari Biorefineries announced that its United States-based patent application, entitled 5-HYDROXY-1,4 NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER? has been granted.

This patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate.